Dr AlSawaf on New Safety Signals With VenetoclaxObinutuzumab in the CLL14 Trial

>> DOWNLOAD LINK 🎞️ #1 <<

>> DOWNLOAD LINK 🎞️ #2 <<

>> COPY / PASTE LINK PLEASE 🎵 MP3 <<

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=rdH1PdRYpuY

Othman Al-Sawaf, MD, a physician with the University Hospital of Cologne in Germany, discusses new safety signals with venetoclax (Venclexta) plus obinutuzumab (Gazyva) in the phase 3 CLL14 trial. • Website: https://www.onclive.com • Twitter:   / onclive   • Facebook:   / onclive   • LinkedIn:   / onclive  

#############################